Return On Equity of NovoCure Ltd from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NovoCure Ltd quarterly and annual Return On Equity in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • NovoCure Ltd Return On Equity for the quarter ending 30 Sep 2025 was -50%, a 21% decline year-over-year.
  • NovoCure Ltd annual Return On Equity for 2024 was -47%, a 9.4% increase from 2023.
  • NovoCure Ltd annual Return On Equity for 2023 was -52%, a 146% decline from 2022.
  • NovoCure Ltd annual Return On Equity for 2022 was -21%, a 43% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

NovoCure Ltd Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -50% -8.8% -21% 01 Jul 2025 30 Sep 2025
Q2 2025 -48% -2.1% -4.5% 01 Apr 2025 30 Jun 2025
Q1 2025 -45% +4.9% +9.7% 01 Jan 2025 31 Mar 2025
Q4 2024 -47% +4.9% +9.4% 01 Oct 2024 31 Dec 2024
Q3 2024 -41% +5.4% +12% 01 Jul 2024 30 Sep 2024
Q2 2024 -46% -5.5% -14% 01 Apr 2024 30 Jun 2024
Q1 2024 -50% -18% -57% 01 Jan 2024 31 Mar 2024
Q4 2023 -52% -31% -146% 01 Oct 2023 31 Dec 2023
Q3 2023 -47% -28% -149% 01 Jul 2023 30 Sep 2023
Q2 2023 -40% -24% -151% 01 Apr 2023 30 Jun 2023
Q1 2023 -32% -18% -125% 01 Jan 2023 31 Mar 2023
Q4 2022 -21% -6.3% -43% 01 Oct 2022 31 Dec 2022
Q3 2022 -19% -12% -190% 01 Jul 2022 30 Sep 2022
Q2 2022 -16% -15% -1264% 01 Apr 2022 30 Jun 2022
Q1 2022 -14% -18% -531% 01 Jan 2022 31 Mar 2022
Q4 2021 -15% -21% -339% 01 Oct 2021 31 Dec 2021
Q3 2021 -6.5% -14% -188% 01 Jul 2021 30 Sep 2021
Q2 2021 -1.2% -6.3% -123% 01 Apr 2021 30 Jun 2021
Q1 2021 3.3% -1.1% -25% 01 Jan 2021 31 Mar 2021
Q4 2020 6.1% +10% 01 Oct 2020 31 Dec 2020
Q3 2020 7.4% +26% 01 Jul 2020 30 Sep 2020
Q2 2020 5.1% +37% 01 Apr 2020 30 Jun 2020
Q1 2020 4.4% +52% 01 Jan 2020 31 Mar 2020
Q4 2019 -4.2% +53% +93% 01 Oct 2019 31 Dec 2019
Q3 2019 -18% +34% +65% 01 Jul 2019 30 Sep 2019
Q2 2019 -32% +21% +39% 01 Apr 2019 30 Jun 2019
Q1 2019 -47% +9.5% +17% 01 Jan 2019 31 Mar 2019
Q4 2018 -57% -5.3% -10% 01 Oct 2018 31 Dec 2018
Q3 2018 -53% +5% +8.6% 01 Jul 2018 30 Sep 2018
Q2 2018 -52% +17% +25% 01 Apr 2018 30 Jun 2018
Q1 2018 -57% +18% +24% 01 Jan 2018 31 Mar 2018
Q4 2017 -52% +23% +31% 01 Oct 2017 31 Dec 2017
Q3 2017 -58% +12% +17% 01 Jul 2017 30 Sep 2017
Q2 2017 -69% -0.17% -0.24% 01 Apr 2017 30 Jun 2017
Q1 2017 -74% 01 Jan 2017 31 Mar 2017
Q4 2016 -75% 01 Oct 2016 31 Dec 2016
Q3 2016 -70% 01 Jul 2016 30 Sep 2016
Q2 2016 -69% 01 Apr 2016 30 Jun 2016

NovoCure Ltd Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -47% +4.9% +9.4% 01 Jan 2024 31 Dec 2024
2023 -52% -31% -146% 01 Jan 2023 31 Dec 2023
2022 -21% -6.3% -43% 01 Jan 2022 31 Dec 2022
2021 -15% -21% -339% 01 Jan 2021 31 Dec 2021
2020 6.1% +10% 01 Jan 2020 31 Dec 2020
2019 -4.2% +53% +93% 01 Jan 2019 31 Dec 2019
2018 -57% -5.3% -10% 01 Jan 2018 31 Dec 2018
2017 -52% +23% +31% 01 Jan 2017 31 Dec 2017
2016 -75% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.